{"protocolSection":{"identificationModule":{"nctId":"NCT06481943","orgStudyIdInfo":{"id":"SB-ACS-003"},"organization":{"fullName":"SB Technology, Inc.","class":"INDUSTRY"},"briefTitle":"A Prospective Research Investigation of Ischemia Using MCG","officialTitle":"A Prospective Research Investigation of Ischemia Using SandboxAQ Magnetocardiography Device","acronym":"PRISM"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-07","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2025-03","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-06","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-25","studyFirstSubmitQcDate":"2024-06-25","studyFirstPostDateStruct":{"date":"2024-07-01","type":"ESTIMATED"},"lastUpdateSubmitDate":"2024-06-25","lastUpdatePostDateStruct":{"date":"2024-07-01","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"SB Technology, Inc.","class":"INDUSTRY"},"collaborators":[{"name":"Mayo Clinic","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":true,"isUnapprovedDevice":true,"isUsExport":false},"descriptionModule":{"briefSummary":"PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status."},"conditionsModule":{"conditions":["Acute Coronary Syndrome"],"keywords":["Magnetocardiography","MCG"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":150,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"ACS","description":"Adult patients who are undergoing a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute coronary syndrome (ACS). Patients are further classified as having low, medium, and high risk for ACS.","interventionNames":["Device: Sponsor MCG device (CardiAQ)"]}],"interventions":[{"type":"DEVICE","name":"Sponsor MCG device (CardiAQ)","description":"Unshielded magnetocardiography device for measuring cardiac magnetic fields","armGroupLabels":["ACS"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Relationship between pre-procedural MCG and the peri-procedural angiography-based measures","description":"Utilize linear regression and logistic regression to determine whether a set of a priori MCG-based biomarkers can prospectively predict the objective clinical assessment of ACS, while statistically adjusting for covariates.","timeFrame":"Data taken within 24 hours of each other"}],"secondaryOutcomes":[{"measure":"Sponsor MCG device safety","description":"Device-related adverse events","timeFrame":"30 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Scheduled to undergo a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute myocardial infarction\n* Ability for participant to comply with study requirements\n* Patient consented before the planned, clinically indicated cath-lab procedure begins to allow sufficient time for study related activities\n* Written informed consent\n\nExclusion Criteria:\n\n* Present STEMI\n* Pregnant or breastfeeding\n* Having an active atrial fibrillation episode as seen on most current 12-lead ECG\n* Active thoracic metal implant\n* Poor access to follow-up","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Adult patients who are undergoing a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute coronary syndrome (ACS).","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Maggie LeDang","role":"CONTACT","phone":"408-981-8754","email":"clinical-trials@sandboxquantum.com"}],"overallOfficials":[{"name":"Kit Yee Au-Yeung, PhD","affiliation":"SB Technology, Inc.","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Mayo Clinic","city":"Rochester","state":"Minnesota","zip":"55905","country":"United States","contacts":[{"name":"Mohamad A Alkhouli, MD, MBA","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":44.02163,"lon":-92.4699}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"meshes":[{"id":"D000054058","term":"Acute Coronary Syndrome"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000017202","term":"Myocardial Ischemia"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000014652","term":"Vascular Diseases"}],"browseLeaves":[{"id":"M10543","name":"Ischemia","asFound":"Ischemia","relevance":"HIGH"},{"id":"M27545","name":"Acute Coronary Syndrome","asFound":"Acute Coronary Syndrome","relevance":"HIGH"},{"id":"M16355","name":"Syndrome","relevance":"LOW"},{"id":"M6546","name":"Coronary Artery Disease","relevance":"LOW"},{"id":"M19506","name":"Myocardial Ischemia","relevance":"LOW"},{"id":"M9419","name":"Heart Diseases","relevance":"LOW"},{"id":"M17400","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}